PHI with malaria vaccination
How does this condition affect your private health insurance?
Malariaimpfung (Malaria vaccination) refers to the administration of vaccines designed to prevent malaria, a life-threatening parasitic disease. Currently, the RTS,S/AS01 (Mosquirix) vaccine is approved and recommended for young children in areas with moderate to high malaria transmission. It works by targeting the P. falciparum parasite, the most lethal malaria species. While highly effective in reducing severe malaria cases and deaths, it does not offer complete protection. Common side effects are usually mild and temporary, including pain, swelling, or fever at the injection site, reflecting the immune system's response to the vaccine.
PKV Risk Assessment
Impact on Your Insurance Policy
Duration of Illness (Initial)
1-2 days (referring to mild vaccine side effects like fever or injection site reaction)
Duration of Illness (Lifetime)
One-time event per dose (referring to vaccine side effects)
Cost of Treatment (Initial)
Cost of one vaccine dose (varies by region and program, e.g., $5-$10 per dose in some settings)
Cost of Treatment (Lifetime)
Cost of full vaccine course, typically 3-4 doses plus potential boosters, potentially $15-$40 or more
Mortality Rate
Extremely low (<0.0001%, typically from severe allergic reaction to vaccine components)
Risk of Secondary Damages
Extremely low (<0.01%, referring to rare, severe, and lasting vaccine side effects)
Probability of Full Recovery
Very high, nearly 100% (for recovery from any mild vaccine side effects)
Underlying Disease Risk
Negligible, as the vaccine prevents disease rather than causing it or predisposing to others